+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rapid Diagnostics Market - Global Forecast 2026-2032- Product Image
Rapid Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Rapid Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012257
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The rapid diagnostics market is experiencing transformative change, driven by the shift toward decentralized care, technological advancements, and evolving operational requirements. As organizations seek to balance speed, dependability, and innovation, strategic decision-makers play a vital role in shaping diagnostics adoption and driving performance in this dynamic environment.

Market Snapshot: Rapid Diagnostics Market Size & Growth

The rapid diagnostics market expanded from USD 19.08 billion in 2025 to USD 21.01 billion in 2026, and is projected to achieve a compound annual growth rate (CAGR) of 14.30%, reaching USD 48.65 billion by 2032. Market momentum is propelled by increased need for fast, accurate, point-of-need testing across clinical and non-clinical settings. Ongoing investment in cutting-edge decentralized solutions and technology improvements further support rapid diagnostics adoption among a broadened user base, while market leaders focus on delivering operational resilience and enhancing supply chain effectiveness.

Scope & Segmentation of the Rapid Diagnostics Market

  • Product Types: Benchtop instruments are utilized for centralized testing, while portable devices enable diagnostics at the point of care; reagents, consumables, and integrated test kits ensure seamless workflows in diverse settings.
  • Technology Classes: Immunoassays and lateral flow assays—offering both competitive and sandwich formats—underpin many rapid tests. Isothermal molecular diagnostics and PCR-based solutions provide additional flexibility for rapid disease detection and ongoing monitoring.
  • End Users: Hospitals, reference laboratories, clinics, and homecare providers each have unique needs regarding throughput, technology compatibility, and procurement strategy to ensure efficient diagnostics operations.
  • Clinical Applications: Rapid tests cover cardiac markers such as troponin and myoglobin, diabetes monitoring for both Type 1 and Type 2, infectious disease diagnosis spanning bacterial, viral, and parasitic illnesses, and specialized oncology panels for early detection and treatment optimization.
  • Regional Markets: The Americas, Europe/Middle East/Africa (EMEA), and Asia-Pacific regions present distinct regulatory, reimbursement, and infrastructure requirements, making regional strategy and compliance essential for market entry and sustained presence.

Key Takeaways: Strategic Insights for Senior Leaders

  • Rapid diagnostic tools have evolved into integral components within routine care pathways, supporting clinical decision-making and enhancing care quality at multiple levels.
  • Technological innovation, including advances in assay chemistry, device miniaturization, and digital integration, is progressively narrowing the gap between point-of-care and laboratory diagnostics.
  • Comprehensive digital solutions, which incorporate real-time data aggregation and remote monitoring, are enabling streamlined implementation for healthcare networks and homecare systems.
  • Procurement teams increasingly prioritize operational resilience, focusing on diverse supplier relationships and strategic sourcing to mitigate risks associated with disruptions or component obsolescence.
  • Modular platforms and bundled service options, supported by robust clinical evidence, have become pivotal for companies aiming to secure preference with purchasers and payers seeking both clinical performance and economic value.
  • Early engagement with regulatory authorities, the adoption of value-based pricing, and thorough post-market surveillance are crucial for establishing market confidence and long-term adoption.

Tariff Impact: Implications for Sourcing and Commercial Strategy

Recent tariff changes in the United States, introduced in 2025, are reshaping procurement, manufacturing, and distribution strategies within the rapid diagnostics ecosystem. Companies are reevaluating supply chains by implementing nearshoring and redesigning products to lessen exposure to tariff-impacted components. This approach leads to new supplier negotiations, increased investment in distributed production, and adoption of dual sourcing tactics. Procurement teams are embedding contingency clauses into contracts to address tariff volatility, while pricing models are adjusted to emphasize fulfillment speed and reliable supply continuity. These shifts underscore the necessity for adaptability in both operational planning and broader market access strategies.

Methodology & Data Sources

This market research leverages a mixed-methods approach, combining primary interviews with clinical, procurement, and regulatory experts with comprehensive reviews of clinical publications, device registries, and public procurement datasets. Scenario-driven validation and expert iteration ensure that research findings accurately reflect practical challenges and solutions in real-world diagnostics implementation.

Why This Report Matters

  • Delivers strategic insight to senior executives for informed technology investment, market positioning, and sourcing strategies in a rapidly evolving diagnostics sector.
  • Provides a segmentation-led framework that links product innovation to regional strategy and clinical use, supporting targeted operational decisions.
  • Enables risk-aware decision-making with a focus on regulatory alignment, resilient supply chains, and effective stakeholder engagement across procurement, clinical, and commercial functions.

Conclusion

As demands on the rapid diagnostics market continue to evolve, organizations that align product modularity and supply chain resilience with shifting care models will be optimally positioned to deliver both clinical and commercial outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Rapid Diagnostics Market, by Product Type
8.1. Instruments
8.1.1. Benchtop
8.1.2. Portable
8.2. Reagents & Consumables
8.3. Test Kits
9. Rapid Diagnostics Market, by Technology
9.1. Immunoassay
9.2. Lateral Flow Assay
9.2.1. Competitive
9.2.2. Sandwich
9.3. Molecular Diagnostics
9.3.1. Isothermal Amplification
9.3.2. Pcr
10. Rapid Diagnostics Market, by End User
10.1. Clinics
10.2. Home Care
10.3. Hospitals
10.4. Laboratories
11. Rapid Diagnostics Market, by Application
11.1. Cardiac Markers
11.1.1. Creatine Kinase Mb
11.1.2. Myoglobin
11.1.3. Troponin
11.2. Diabetes
11.2.1. Type 1 Diabetes
11.2.2. Type 2 Diabetes
11.3. Infectious Diseases
11.3.1. Bacterial Infections
11.3.2. Parasitic Infections
11.3.3. Viral Infections
11.4. Oncology
12. Rapid Diagnostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Rapid Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Rapid Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Rapid Diagnostics Market
16. China Rapid Diagnostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ACON Laboratories, Inc.
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. Danaher Corporation
17.11. DiaSorin S.p.A.
17.12. EKF Diagnostics Holdings plc
17.13. F. Hoffmann-La Roche Ltd.
17.14. Hologic, Inc.
17.15. QIAGEN N.V.
17.16. QuidelOrtho Corporation
17.17. Siemens Healthineers AG
17.18. Sysmex Corporation
17.19. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY CREATINE KINASE MB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY MYOGLOBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TROPONIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY TYPE 2 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY BACTERIAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY VIRAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 141. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 147. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 163. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 173. AFRICA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 189. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 191. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 195. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 196. ASEAN RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 197. GCC RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GCC RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. GCC RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 200. GCC RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. GCC RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 202. GCC RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 203. GCC RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. GCC RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. GCC RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 206. GCC RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 207. GCC RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 219. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 224. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 225. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 228. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 229. BRICS RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 230. G7 RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. G7 RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 233. G7 RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. G7 RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 235. G7 RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 236. G7 RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. G7 RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. G7 RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 239. G7 RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 240. G7 RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 241. NATO RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. NATO RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. NATO RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 244. NATO RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. NATO RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 246. NATO RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 247. NATO RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. NATO RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. NATO RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 250. NATO RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 251. NATO RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 264. CHINA RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 267. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, 2018-2032 (USD MILLION)
TABLE 269. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 270. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 273. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2032 (USD MILLION)
TABLE 274. CHINA RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Rapid Diagnostics market report include:
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 21.01 Billion
Forecasted Market Value ( USD ) by 2032 $ 48.65 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

RSV Diagnostics Market - Global Forecast 2026-2032 - Product Image

RSV Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Respiratory Infection Diagnostics Market - Global Forecast 2026-2032 - Product Image

Respiratory Infection Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Rapid Medical Diagnostic Kits - Global Strategic Business Report - Product Image

Rapid Medical Diagnostic Kits - Global Strategic Business Report

  • Report
  • 166 Pages
  • Global
From
Rapid Diagnostics Global Market Report 2025 - Product Image

Rapid Diagnostics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Viral Diagnostic Test Kits Market Report 2025 - Product Image

Viral Diagnostic Test Kits Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.